Search research articles
Contact Us
Filters
Showing results (91-100 of 104) with videos related to
Page
of 11
Sort By:
Biorxiv : the Preprint Server for Biology
|
March 24, 2021
The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells
Xiaodong Zhuang, Senko Tsukuda, Florian Wrensch, et al.
Journal of Hepatology
|
August 22, 2024
Targeting the liver clock improves fibrosis by restoring TGF-β signaling
Emilie Crouchet, Mayssa Dachraoui, Frank Jühling, et al.
Iscience
|
September 21, 2021
The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells
Xiaodong Zhuang, Senko Tsukuda, Florian Wrensch, et al.
The Journal of Clinical Investigation
|
September 11, 2025
Targeting peroxiredoxin 2 prevents hepatocarcinogenesis in metabolic liver disease models
Emilie Crouchet, Eugénie Schaeffer, Marine A Oudot, et al.
JCI Insight
|
July 8, 2022
Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivation
Emilie Crouchet, Shen Li, Mozhdeh Sojoodi, et al.
Gut
|
March 29, 2020
Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma
Frank Jühling, Nourdine Hamdane, Emilie Crouchet, et al.
Egastroenterology
|
March 24, 2025
Protein tyrosine phosphatase delta is a STAT3-phosphatase and suppressor of metabolic liver disease
Armando Andres Roca Suarez, Frank Jühling, Julien Moehlin, et al.
Gastroenterology
|
March 6, 2019
HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response
Nourdine Hamdane, Frank Jühling, Emilie Crouchet, et al.
Science Translational Medicine
|
June 3, 2026
Claudin-1 targeting suppresses tumor growth, invasion, and metastasis in patient-derived cholangiocarcinoma models
Zeina Nehme, Marion Muller, Jade Brochon, et al.
Nature Communications
|
August 29, 2024
An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infection
Atish Mukherji, Frank Jühling, Yogy Simanjuntak, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 104) with videos related to
Sort By:
Page
of 11
Biorxiv : the Preprint Server for Biology
|
March 24, 2021
The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells
Xiaodong Zhuang, Senko Tsukuda, Florian Wrensch, et al.
Journal of Hepatology
|
August 22, 2024
Targeting the liver clock improves fibrosis by restoring TGF-β signaling
Emilie Crouchet, Mayssa Dachraoui, Frank Jühling, et al.
Iscience
|
September 21, 2021
The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells
Xiaodong Zhuang, Senko Tsukuda, Florian Wrensch, et al.
The Journal of Clinical Investigation
|
September 11, 2025
Targeting peroxiredoxin 2 prevents hepatocarcinogenesis in metabolic liver disease models
Emilie Crouchet, Eugénie Schaeffer, Marine A Oudot, et al.
JCI Insight
|
July 8, 2022
Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivation
Emilie Crouchet, Shen Li, Mozhdeh Sojoodi, et al.
Gut
|
March 29, 2020
Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma
Frank Jühling, Nourdine Hamdane, Emilie Crouchet, et al.
Egastroenterology
|
March 24, 2025
Protein tyrosine phosphatase delta is a STAT3-phosphatase and suppressor of metabolic liver disease
Armando Andres Roca Suarez, Frank Jühling, Julien Moehlin, et al.
Gastroenterology
|
March 6, 2019
HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response
Nourdine Hamdane, Frank Jühling, Emilie Crouchet, et al.
Science Translational Medicine
|
June 3, 2026
Claudin-1 targeting suppresses tumor growth, invasion, and metastasis in patient-derived cholangiocarcinoma models
Zeina Nehme, Marion Muller, Jade Brochon, et al.
Nature Communications
|
August 29, 2024
An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infection
Atish Mukherji, Frank Jühling, Yogy Simanjuntak, et al.
Page
of 11